Pabosini pamwe necetuximab yekurapa kenza yemusoro nemutsipa ne70% yekudzikisira

Share This Post

Zvinoenderana nemhedzisiro yakaziviswa pamusangano wepagore we2018 ASCO, CDK4/6 inhibitors pabociclib (Ibrance) uye cetuximab (Erbitux) yakasanganiswa kurapwa kweplatinamu-inodzivirira uye HPV-yakasununguka inodzokororwa / metastatic musoro nemutsipa Iyo yakazara mhinduro yevarwere vane squamous. cell carcinoma (HNSCC) i39%. Mune isina-randomized, 3-ruoko, chikamu II kuyedza (NCT02101034), mhedzisiro yeboka rezvidzidzo ine yepakati-yemahara yekurarama (PFS) yemwedzi 5.4, yepakati pese kupona (OS) ye9.5 mwedzi, uye a 1-gore OS Muyero i35%.

Muchidzidzo ichi, varwere makumi matatu vane HNSCC isina hukama neHPV vakafambira mberi mushure meplatinum-based therapy yekudzokazve / metastatic chirwere uye vakapinda muyedzo. Varwere vakambogamuchira cetuximab yekudzokazve uye HPV-inoenderana neoropharyngeal cancer vaive vasina kukodzera. Varwere vakagamuchira palbociclib kubva pazuva 30 kusvika zuva 1, 21 mg zuva nezuva; cetuximab, ine chiyero chekutanga che 125 mg / m 400 uye ipapo 2 mg / m 250 pavhiki kwemazuva makumi maviri nemasere kusvikira chirwere ichi chichienderera mberi kana kubvisa chidzidzo. Vatsvagiri vakaita bvunzo dzekufungidzira vasati varapwa uye mushure mega ega 2 kutenderera.

Iyo yepakati zera yevarwere yaive makore makumi matanhatu nemanomwe, uye nzvimbo dzemota dzaive dzemuromo mhango (67%), larynx (47%), uye oropharynx (27%). 13% yevarwere vane metastases yemunharaunda, 20% vane metastases ari kure, uye 27% vane zvese zviri zviviri. Gumi neshanu (53%) varwere vakagamuchira treatments 50 kurapwa.

Pakati pevarwere makumi maviri nemasere vanoongororwa, 28 (11%) vaive nemamota mhinduro, kusanganisira 39 (3%) mhinduro dzakazara uye 11 (8%) mhinduro shoma. Vane gumi nemana (29%) varwere vaive nezvirwere zvakagadzikana, 50 (3%) varwere vaive nekufambira mberi, uye 11% yakadzora mamota maronda.

Muongorori Dr. Adkins akataura kuti Palbociclib uye cetuximab vane yakasimba antitumor basa muplatinamu-inodzivirira HPV-inomirira kenza yemutsipa nemutsipa, uye biologically tarisiro yekurapa kweHPV-yakazvimirira yegomarara yemusoro nemutsipa inzira inoshanda yekurapa. . Isu tinotarisira kune zvirinani mhedzisiro yekutsvaga yekutevera.

Subscribe To Newsletter Vedu

Wana zvigadziriso uye usambopotsa blog kubva kuCancerfax

Zvimwe Kuti Uongorore

Kunzwisisa Cytokine Release Syndrome: Zvinokonzera, Zviratidzo, uye Kurapa
CAR T-Cell kurapa

Kunzwisisa Cytokine Release Syndrome: Zvinokonzera, Zviratidzo, uye Kurapa

Cytokine Release Syndrome (CRS) is immune system reaction inowanzo kukonzerwa nemamwe marapirwo senge immunotherapy kana CAR-T cell therapy. Zvinosanganisira kuburitswa kwakanyanya kwemacytokines, zvichikonzera zviratidzo kubva pafivha uye kuneta kusvika kune zvinogona kuuraya hupenyu sekukuvadzwa kwenhengo. Kutungamira kunoda kunyatsotarisisa uye nzira dzekupindira.

Basa revaparamedics mukubudirira kweCAR T Cell therapy
CAR T-Cell kurapa

Basa revaparamedics mukubudirira kweCAR T Cell therapy

Paramedics inobata basa rakakosha mukubudirira kweCAR T-cell therapy nekuona kuchengetwa kwemurwere pasina musono panguva yese yekurapa. Vanopa rubatsiro rwakakosha panguva yekufambisa, kutarisa zviratidzo zvinokosha zvevarwere, uye kupa rubatsiro rwechimbichimbi kana matambudziko amuka. Kupindura kwavo nekukurumidza uye kutarisirwa kwehunyanzvi kunobatsira mukuchengetedzeka kwese uye kushanda kwekurapa, kufambisa shanduko yakapfava pakati pezvirongwa zvehutano uye kuvandudza mhedzisiro yevarwere munzvimbo yakaoma yemhando yepamusoro cellular therapies.

Kuda rubatsiro? Chikwata chedu chakagadzirira kukubatsira.

Tinoshuvira kupora nekukurumidza kwemudiwa wako uye padyo neuyo.

Kutanga kutaura
Tiri paIndaneti! Taura Nesu!
Skena kodhi
Mhoro,

Kugamuchirwa kuCancerFax!

CancerFax ipuratifomu yekupayona yakatsaurirwa kubatanidza vanhu vakatarisana negomarara repamberi nekurapa kwesero seCAR T-Cell therapy, TIL kurapwa, uye miedzo yekiriniki pasi rese.

Tizivise zvatinogona kukuitira.

1) Kurapwa kwegomarara kunze kwenyika?
2) CAR T-Cell therapy
3) Mushonga wegomarara
4) Online vhidhiyo kubvunza
5) Proton kurapwa